IDiyas

For the Inventor, By the Inventor

Greenwood, IN, United States of America

Paul Luther Skatrud

USPTO Granted Patents = 42 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 127(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1997 - 2001)
  • Greenwood, IN (US) (1988 - 2007)

Company Filing History:

goldMedal40 out of 4,442 
 
Eli Lilly and Company
 patents
silverMedal1 out of 32 
 
Miami University
 patents
where one patent can have more than one assignee

Years Active: 1988-2007

Loading Chart...
42 patents (USPTO):Explore Patents
1. 7169919 - Process for preparing lipid II (2007-01-30),
2. H0002071 - Streptococcus pneumoniae gene HI0454 (2003-07-01),
3. H0002019 - Streptococcus pneumoniae gene sequence HI1648 (2002-04-02),
4. 6350866 - Streptococcus pneumoniae gene sequence FtsZ (2002-02-26),
5. 6322998 - Recombinant DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium (2001-11-27),
6. 6271000 - Streptococcus pneumoniae gene sequence mraY (2001-08-07),
7. 6228615 - Multiple drug resistance gene atrD of Aspergillus nidulans (2001-05-08),
8. 6180361 - Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase (2001-01-30),
9. 6171834 - Muri protein from Streptococcus pneumoniae (2001-01-09),
10. 6143868 - Monofunctional glycosyltransferase of Staphylococcus aureus (2000-11-07),
11. 6136557 - Strepococcus pneumoniae gene sequence FtsH (2000-10-24),
12. 6074847 - Streptococcus pneumoniae gene sequence HI1146 (2000-06-13),
13. 6060264 - Multiple drug resistance gene atrc of Aspergillus nidulans (2000-05-09),
14. 5958730 - Streptococcus pneumoniae gene sequence FtsY (1999-09-28),
15. 5948645 - Biosynthetic gene muri from Streptococcus pneumoniae (1999-09-07),

Title: The Innovations of Paul Luther Skatrud: A Pioneer in Biomedical Research

Introduction: Paul Luther Skatrud, a renowned inventor based in Greenwood, IN, has made significant contributions to the field of biomedical research. With an impressive portfolio of 42 patents, Skatrud stands as a key figure in the development of groundbreaking technologies.

Latest Patents: Among Skatrud's latest patents is a revolutionary process for preparing lipid II, a vital substrate for bacterial cell wall biosynthesis. This chemical synthesis method provides a sustainable source of lipid II, opening doors for the discovery of novel therapeutic agents targeting bacterial infections. Additionally, Skatrud's invention of the Streptococcus pneumoniae gene HI0454 showcases his expertise in molecular biology and genetic engineering.

Career Highlights: Skatrud's illustrious career includes stints at prestigious companies such as Eli Lilly and Company and Miami University. His innovative research methodologies and in-depth understanding of biological systems have led to the development of cutting-edge technologies in the pharmaceutical and biotech sectors.

Collaborations: Throughout his career, Skatrud has collaborated with esteemed professionals in the field, including Robert Brown Peery and Jo Ann Hoskins. These collaborations have resulted in synergistic efforts to drive innovation and transform concepts into tangible solutions.

Conclusion: Paul Luther Skatrud's remarkable journey as an inventor exemplifies his unwavering commitment to advancing biomedical research and creating impactful technologies. His pioneering work continues to inspire the next generation of innovators in the pursuit of groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…